Citation 1:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,00
    Location: chars 885–1045

Citation 2:
    Title: Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
    URL: https://apnews.com/article/ca026922525a9e3abb1b75d329628bef#:~:text=below%20Wall%20Street%20expectations%20but,1%20receptor%20agonists%20class
    Location: chars 1046–1204

Citation 3:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,00
    Location: chars 1266–1426

Citation 4:
    Title: Lilly forecasts 2025 profit growth after recent weight-loss drug worries
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-forecasts-2025-profit-largely-above-estimates-launch-weight-loss-drug-2025-02-06/#:~:text=leading%20diabetes%20drug%20Mounjaro%20in,00%2C%20slightly%20above%20analyst%20expectations
    Location: chars 1427–1699

Citation 5:
    Title: Lilly set for strong quarter after Novo profit warning
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-set-strong-quarter-after-novo-profit-warning-2025-07-29/#:~:text=Eli%20Lilly%20is%20anticipated%20to,Despite%20this
    Location: chars 1789–1991

Citation 6:
    Title: Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-raises-full-year-earnings-forecasts-surging-demand-weight-loss-drug-2025-08-07/#:~:text=The%20weight,38%20billion%E2%80%94both%20exceeding%20analyst%20expectations
    Location: chars 2131–2381

Citation 7:
    Title: Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-raises-full-year-earnings-forecasts-surging-demand-weight-loss-drug-2025-08-07/#:~:text=The%20weight,38%20billion%E2%80%94both%20exceeding%20analyst%20expectations
    Location: chars 2461–2711

Citation 8:
    Title: US FDA approves gradual dosing for Lilly Alzheimer's drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gradual-dosing-lilly-alzheimers-drug-2025-07-09/#:~:text=The%20U,as%20two%20vials%20monthly%20before
    Location: chars 2808–3005

Citation 9:
    Title: EU regulator backs Eli Lilly's Alzheimer's drug after initial rejection
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-eli-lillys-alzheimers-drug-after-initial-rejection-2025-07-25/#:~:text=The%20European%20Medicines%20Agency%20,as%20one%20of%20the%20few
    Location: chars 3039–3274

Citation 10:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,daily
    Location: chars 3362–3525

Citation 11:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 3651–3823

Citation 12:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,to%20%245.32
    Location: chars 3824–3994

Citation 13:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=County%2C%20Wisconsin%2C%20with%20a%20%243,program%20and%2C%20for%20the%20seventh
    Location: chars 4147–4385

Citation 14:
    Title: Lilly weight-loss pill helps patients shed 12.4% of body weight in trial
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-pill-helps-patients-shed-124-body-weight-trial-2025-08-07/#:~:text=Eli%20Lilly%20announced%20that%20its,loss%20in%20an%20earlier%202021
    Location: chars 4511–4745

Citation 15:
    Title: Eli Lilly raises full-year profit forecast on weight-loss drug strength
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-raises-full-year-profit-forecast-weight-loss-drug-strength-2025-08-07/#:~:text=outlook%2C%20Eli%20Lilly%E2%80%99s%20shares%20fell,loss%20over%2068
    Location: chars 4793–5030

Citation 16:
    Title: Lilly's GLP-1 pill cuts body weight by 12.4% in trial, lagging Novo's injection
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-glp-1-pill-cuts-body-weight-by-124-trial-lagging-novos-injection-2025-08-07/#:~:text=Eli%20Lilly%20announced%20that%20its,Lilly%E2%80%99s%20stock%20dropped%20about%2014
    Location: chars 5031–5287

Citation 17:
    Title: Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
    URL: https://www.reuters.com/sustainability/boards-policy-regulation/lilly-appeal-after-uk-agency-opposes-reimbursement-alzheimers-drug-2025-06-18/#:~:text=Eli%20Lilly%20announced%20plans%20to,Kisunla%2C%20approved%20in%20the
    Location: chars 5465–5706

Citation 18:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=Eli%20Lilly%20and%20Company%20,single%20business%20segment%E2%80%94human%20pharmaceutical%20products
    Location: chars 6203–6410

Citation 19:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 6828–7000

Citation 20:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=U.S.%20%20,20
    Location: chars 7093–7213

Citation 21:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=Eli%20Lilly%20and%20Company%20,single%20business%20segment%E2%80%94human%20pharmaceutical%20products
    Location: chars 7489–7696

Citation 22:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 7697–7869

Citation 23:
    Title: Lilly lifts annual sales forecast by $3 billion as weight-loss drug powers results
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-raises-annual-profit-forecast-zepbound-quarterly-sales-cross-1-billion-2024-08-08/#:~:text=significant%20weight,4%20billion
    Location: chars 8153–8367

Citation 24:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=County%2C%20Wisconsin%2C%20with%20a%20%243,program%20and%2C%20for%20the%20seventh
    Location: chars 8368–8606

Citation 25:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,00
    Location: chars 8864–9024

Citation 26:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Alzheimer%27s%20disease%3B%20,with%20a%20covalent%20BTK%20inhibitor
    Location: chars 9222–9446

Citation 27:
    Title: Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-raises-full-year-earnings-forecasts-surging-demand-weight-loss-drug-2025-08-07/#:~:text=The%20weight,38%20billion%E2%80%94both%20exceeding%20analyst%20expectations
    Location: chars 9609–9859

Citation 28:
    Title: Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
    URL: https://www.reuters.com/sustainability/boards-policy-regulation/lilly-appeal-after-uk-agency-opposes-reimbursement-alzheimers-drug-2025-06-18/#:~:text=Eli%20Lilly%20announced%20plans%20to,Kisunla%2C%20approved%20in%20the
    Location: chars 10088–10329

Citation 29:
    Title: Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
    URL: https://apnews.com/article/ca026922525a9e3abb1b75d329628bef#:~:text=Lilly%27s%20quarterly%20profit%20reached%20%244,due%20to%20additional%20approvals%20and
    Location: chars 10589–10760

Citation 30:
    Title: Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-raises-full-year-earnings-forecasts-surging-demand-weight-loss-drug-2025-08-07/#:~:text=The%20weight,38%20billion%E2%80%94both%20exceeding%20analyst%20expectations
    Location: chars 10792–11042

Citation 31:
    Title: Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-raises-full-year-earnings-forecasts-surging-demand-weight-loss-drug-2025-08-07/#:~:text=The%20weight,38%20billion%E2%80%94both%20exceeding%20analyst%20expectations
    Location: chars 11150–11400

Citation 32:
    Title: EU regulator backs Eli Lilly's Alzheimer's drug after initial rejection
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-eli-lillys-alzheimers-drug-after-initial-rejection-2025-07-25/#:~:text=The%20European%20Medicines%20Agency%20,as%20one%20of%20the%20few
    Location: chars 11530–11765

Citation 33:
    Title: US FDA approves gradual dosing for Lilly Alzheimer's drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gradual-dosing-lilly-alzheimers-drug-2025-07-09/#:~:text=The%20U,as%20two%20vials%20monthly%20before
    Location: chars 11766–11963

Citation 34:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,daily
    Location: chars 12039–12202

Citation 35:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 12301–12473

Citation 36:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=County%2C%20Wisconsin%2C%20with%20a%20%243,program%20and%2C%20for%20the%20seventh
    Location: chars 12682–12920

Citation 37:
    Title: Lilly weight-loss pill helps patients shed 12.4% of body weight in trial
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-pill-helps-patients-shed-124-body-weight-trial-2025-08-07/#:~:text=Eli%20Lilly%20announced%20that%20its,loss%20in%20an%20earlier%202021
    Location: chars 13203–13437

Citation 38:
    Title: Eli Lilly raises full-year profit forecast on weight-loss drug strength
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-raises-full-year-profit-forecast-weight-loss-drug-strength-2025-08-07/#:~:text=outlook%2C%20Eli%20Lilly%E2%80%99s%20shares%20fell,loss%20over%2068
    Location: chars 13492–13729

Citation 39:
    Title: Eli Lilly's third quarter earnings miss and forecast cut lead to sharp stock drop
    URL: https://apnews.com/article/95488719d0d9a4fbb166df4ced097f0b#:~:text=research%2C%20development%2C%20and%20administrative%20expenses,date
    Location: chars 13925–14076

Citation 40:
    Title: Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
    URL: https://www.reuters.com/sustainability/boards-policy-regulation/lilly-appeal-after-uk-agency-opposes-reimbursement-alzheimers-drug-2025-06-18/#:~:text=Eli%20Lilly%20announced%20plans%20to,Kisunla%2C%20approved%20in%20the
    Location: chars 14257–14498

Citation 41:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 14935–15107

Citation 42:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=each%20of%20Trulicity%2C%20Mounjaro%2C%20Verzenio%2C,1%20receptor
    Location: chars 15596–15768

Citation 43:
    Title: lly-20231231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm#:~:text=U.S.%20%20,20
    Location: chars 16327–16447

Citation 44:
    Title: Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
    URL: https://www.reuters.com/sustainability/boards-policy-regulation/lilly-appeal-after-uk-agency-opposes-reimbursement-alzheimers-drug-2025-06-18/#:~:text=Eli%20Lilly%20announced%20plans%20to,Kisunla%2C%20approved%20in%20the
    Location: chars 17291–17532

Citation 45:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=County%2C%20Wisconsin%2C%20with%20a%20%243,program%20and%2C%20for%20the%20seventh
    Location: chars 18366–18604

Citation 46:
    Title: Lilly ESG Report Highlights Progress Towards Sustainability Goals | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-esg-report-highlights-progress-towards-sustainability#:~:text=Reduced%20greenhouse%20gas%20emissions%20by,20
    Location: chars 19984–20184

Citation 47:
    Title: Lilly ESG Report Highlights Progress Towards Sustainability Goals | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-esg-report-highlights-progress-towards-sustainability#:~:text=Reduced%20greenhouse%20gas%20emissions%20by,20
    Location: chars 20394–20594

Citation 48:
    Title: Lilly ESG Report Highlights Progress Towards Sustainability Goals | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-esg-report-highlights-progress-towards-sustainability#:~:text=Reduced%20greenhouse%20gas%20emissions%20by,20
    Location: chars 21338–21538

Citation 49:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=County%2C%20Wisconsin%2C%20with%20a%20%243,program%20and%2C%20for%20the%20seventh
    Location: chars 21539–21777

